Skip to main content
. 2017 Sep 12;7:11245. doi: 10.1038/s41598-017-09676-2

Table 1.

Clinicopathological characteristics of patients in the two groups

Variables B-I group N = 70 (%) R-Y group N = 70 (%) P Value
Gender 0.223
  Male 40 (57.1) 47 (67.1)
  Female 30 (42.9) 23 (32.9)
Age 56.3 ± 10.7 54.9 ± 11.5 0.491
Educational Level 0.111
  <7 years 26 (37.1) 17 (24.3)
  7–12 years 29 (41.4) 28 (40.0)
  >12 years 15 (21.4) 25 (35.7)
BMI (kg/m2) 22.4 ± 3.1 22.7 ± 3.5 0.616
Tumor size (cm) 3.6 ± 1.9 4.4 ± 2.6 0.156
Macroscopic type 0.338
  Type 0-2 54 (77.1) 49 (70.0)
  Type 3-4 16 (22.9) 21 (30.0)
Histologic Type 0.494
  Well and Moderate differentiated 13 (18.6) 10 (14.3)
  Poor and undifferentiated 57 (81.4) 60 (85.7)
Lauren classification 0.178
  Intestinal type 27 (38.6) 22 (31.4)
  Diffuse type 38 (54.3) 36 (51.4)
  Mixed type 5 (7.1) 12 (17.1)
Surgical Type 0.699
  Open Surgery 53 (75.7) 51 (72.9)
  Laparoscopic Surgery 17 (24.3) 19 (27.1)
No. of positive LNs 4.6 ± 7.6 4.6 ± 7.0 0.917
No. of examined LNs 32.9 ± 12.5 36.6 ± 18.2 0.173
Depth of invasion 0.303
  T1 27 (38.6) 22 (31.4)
  T2 12 (17.1) 11 (15.7)
  T3/ T4 31 (44.3) 37 (52.9)
Lymph nodes metastasis 0.764
  N0 27 (38.6) 30 (42.9)
  N1 13 (18.6) 10 (14.3)
  N2 15 (21.4) 12 (17.1)
  N3 15 (21.4) 18 (25.7)
TNM stage 0.237
  IA 18 (25.7) 13 (18.6)
  IB 12 (17.1) 9 (12.9)
  IIA 8 (11.4) 8 (11.4)
  IIB 6 (8.6) 11 (15.7)
  IIIA 10 (14.3) 6 (8.6)
  IIIB 3 (4.3) 10 (14.3)
  IIIC 10 (14.3) 9 (12.9)
  IV 3 (4.3) 4 (5.7)
Adjuvant Chemotherapy 0.062
  No 37 (52.9) 26 (37.1)
  Yes 33 (47.1) 44 (62.9)